Individualising Menopausal Hormone Therapy in 2025
Basic Overview
Plenary Lecture
A comprehensive update on personalizing menopausal hormone therapy, incorporating the latest guidelines and delivery systems for optimal patient outcomes.
Session Overview
Key Topics
- Updates from NAMS, IMS, and FOGSI guidelines
- New delivery systems and formulations
- Patient selection and risk stratification
- Monitoring and follow-up protocols
- Evidence-based decision making
Learning Objectives
- Interpret and apply current hormone therapy guidelines in clinical practice
- Evaluate new hormone delivery systems and their applications
- Implement risk stratification for patient selection
- Design appropriate monitoring protocols
- Make evidence-based decisions for individual patients
Target Audience
- Gynecologists
- Endocrinologists
- Primary Care Physicians
- Women’s Health Specialists
- Clinical Researchers
Session Format
- 45-minute lecture
- 15-minute Q&A
- Case presentations
- Interactive discussion
- Clinical pearls sharing
Key Points
Guideline Updates
Rapid updates from NAMS, IMS, FOGSI guidelines for hormone therapy.
Delivery Systems
New and emerging hormone therapy delivery systems and formulations.
Patient Selection
Risk stratification and personalized approach to hormone therapy.
Clinical Clarity
Current evidence supporting individualized treatment decisions.
Speakers